Table 2 In vitro antifungal susceptibility testing of 203 clinical isolates into 5 antifungal agents

C. albicans (77)

Amphotericin B

0

0

0^b

-

Flucytosine

1(1.4)

0

1(1.3)^b

0.791

Fluconazole

9(12.5)

2(40.0)

11(14.3)

0.089

Itraconazole

15(20.8)

2(40.0)

17(22.1)^b

0.318

Voriconazole

13(18.1)

1(20.0)

14(18.2)^b

0.913

 C. glabrata (40)

Amphotericin B

0

0

0^b

0.078

Flucytosine

0

0

0^b

-

Fluconazole

2(5.9)

0

2(5.0)

0.542

Itraconazole

4(11.8)

0

4(10.0)^b

0.376

Voriconazole

0

0

0^b

-

C.tropicalis (41)

Amphotericin B

1(2.9)

0

1(2.4)^b

0.646

Flucytosine

0

0

0^b

-

Fluconazole

12(35.3)

3(42.9)

15(36.6)^b

0.705

Itraconazole

12(35.3)

3(42.9)

15(36.6)^b

0.705

Voriconazole

13(38.2)

3(42.9)

16(39.0)^b

0.819

 C. parapsilosis (33)

Amphotericin B

0

0

0

-

Flucytosine

0

0

0

-

Fluconazole

0

0

0

-

Itraconazole

0

0

0

-

Voriconazole

0

0

0

-

C. krusei (5)

Amphotericin B

0

0

0

-

Flucytosine

1(50.0)

0

1(20.0)^b

0.171

Fluconazole^a

-

-

-

Itraconazole

0

2(66.7)

2(40.0)^b

0.136

Voriconazole

0

1(33.3)

1(20.0)^b

0.361

Others*(7)

Amphotericin B

0

0

0

-

Flucytosine

0

0

0

-

Fluconazole

0

0

0

-

Itraconazole

0

0

0

-

Voriconazole

0

0

0

-

All of isolates (204)

Amphotericin B

1(0.6)

0

1(0.5)

0.642

Flucytosine

2(1.2)

0

2(1.0)

0.509

Fluconazole^a

23(13.9)

5(15.2)

28(14.1)

0.285

Itraconazole

31(18.5)

7(19.4)

38(18.6)

0.902

Voriconazole

26(15.5)

5(13.9)

31(15.2)

0.799